InvestorsHub Logo
Followers 23
Posts 2199
Boards Moderated 0
Alias Born 03/18/2013

Re: Number sleven post# 398185

Saturday, 01/14/2023 11:14:56 AM

Saturday, January 14, 2023 11:14:56 AM

Post# of 426478
Unbelievable; you dudes can stroke each others libido all you want. You know JesseLivermore warned us of not selling out to Big Pharma. Well, that was before the avalanche hit us.

If you think management has done a good job think again. Good job at what? Milking the company and shareholders out of stock options and rewarding themselves wonderful salaries. What have they done really? Only when Alex Denner had the cahones enough to call them out on their lavish lifestyles and bumbling of European acceptance of Vascepa.

Karim made a lot of promises which he hasn't kept. He's hired his old cronies and made sure they were paid well with no accountability and performance goals. Must be pretty nice to live in Zug, Switzerland on a $5 million + a year salary plus stock options. The "silence" is deafening. The non-communication is enough for me to cast my shares for Denner.

Only when approached with the threat of losing their jobs, have they decided to throw the shareholders a bone "with no meat." Show me the money

What is your plan? Because I don't think management has a plan. They still want to go it alone it. This is ludicrous. No partners, all lip service. This drug has a time value. The more time wasted the less chance we have of recovering our investment. Plain and simple.

The only reason the share price has gone up is because of Denner and those familiar with his track record have been buying shares in anticipation of what's about to happen. Denners plan is simple. Find a buyer, negotiate a decent price, do the deal.... Done, we're outta here.

Hopefully, its with a company that has a need for a great drug and pays a good dividend.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News